The role of ras gene mutation in gastric cancer and precancerous lesions

Hao Ying , Zhang Jinkun , Lu Youyong , Yi Cuiqiong , Qian Wei , Cui Jiantao

Current Medical Science ›› 1998, Vol. 18 ›› Issue (3) : 141 -144.

PDF
Current Medical Science ›› 1998, Vol. 18 ›› Issue (3) : 141 -144. DOI: 10.1007/BF02888522
Article

The role of ras gene mutation in gastric cancer and precancerous lesions

Author information +
History +
PDF

Abstract

Abnormality of ras gene family was studied in a total of 206 cases of gastric cancer and precancerous lesions by PCR-RFLP, PCR-SSCP and DNA sequencing. The results showed that mutation rate of H-ras 12 codon in metaplasia, atypical hyperplasia, early-stage cancer and advanced cancer was 16.7%, 31. 2 %, 50. 0 %, and 32. 2 %, respectively. In the groups of superficial gastritis and normal controls, no mutation were detected in codon 12 of ras. Mutations of H-ras 61 codon and N-ras 12 codon in various groups were the same as those in normal control. K-ras 12 codon mutation was detected in only 2 cases of gastric cancer by using PCR-SSCP, but it was not detected by DNA sequencing, which may be polymorphism. All H-ras 12 codon mutations were G→ T mutation. There were significant difference between the groups of metaplasia, dysplasia, gastric carcinoma and normal control group (P < 0.05,P < 0.01,P < 0.01, respectively). It was concluded that H-ras 12 codon mutation was an early event and may play an important role in gastric carcinogenesis. Although K-ras, N-ras mutation rates are high in colon cancer and leukemia, it seems to bear no relationship with gastric cancer.

Keywords

ras gene mutation / PCR/RFLP / PCR/SSCP / DNA-sequencing / gastric cancer / precancerous lesions

Cite this article

Download citation ▾
Hao Ying, Zhang Jinkun, Lu Youyong, Yi Cuiqiong, Qian Wei, Cui Jiantao. The role of ras gene mutation in gastric cancer and precancerous lesions. Current Medical Science, 1998, 18(3): 141-144 DOI:10.1007/BF02888522

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

BarbacidM.. Ras genes. Annu Rev Biochem, 1987, 56: 779-779

[2]

GrunewaldK, LyonsJ, FrohlichA, et al. . High frequency of K-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer, 1989, 43: 1037-1037

[3]

VogelsteinB, FearonE R, HamiltonS R.. Genetic alterations during colorectal tumor development. N Engl J Med, 1988, 319: 525-525

[4]

NanusD M, KelsonD P, MentleI R. Infrequent point mutations of ras oncogenes in gastric cancers. Gastroenterology, 1990, 98(4): 955-955

[5]

VictorT, Ku-ToitR, JordaanA M.. No evidence for point mutations in codon 12, 13 and 61 of the ras gene in a high incidence area for esophageal and gastric cancers. Cancer Research, 1990, 50(16): 4911-4911

[6]

DengG R, LiuS A, WangJ R. Correlation of mutations oncogene c-H-ras at codon 12 with metastasis and survival of gastric cancer patients. Oncogene Research, 1991, 6: 33-33

[7]

KohE H, ChungH C, LeeK B. Point mutation at codon 12 of the H-ras gene in human gastric cancers. J Korean Med Sci, 1992, 217(12): 110-110

[8]

KihanaT, TsudaH, HirotaT, et al. . Point mutation of c-k-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Research, 1991, 82(3): 308-308

[9]

MikiH, OhmoriM, PerantoniA O.. K-ras activation in gastric epiethelial tumors in Japanese. Cancer Lett, 1991, 58(1-2): 107-107

AI Summary AI Mindmap
PDF

86

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/